<p>2025 年 11 月 19 日- 上午 09:15</p>
<p>德克萨斯州奥斯汀，2025 年 11 月 19 日（GLOBE NEWSWIRE）-- Astrotech Corporation（纳斯达克：ASTC）（“公司” 或 “Astrotech”）今天宣布，其董事会已启动战略选择的审查，以探索最大化股东价值的方法。该审查将包括一系列潜在行动，包括筹集股本、反向合并、组合交易以及出售公司全部或部分业务，以及其他可能的战略或财务交易。</p>
<p>“我们对我们独特的质谱和气相色谱技术，以及我们为在大型终端市场（如爆炸物痕迹检测、毒品痕迹检测、安全筛查、环境测试和工业控制）创造价值而开发的特定终端市场应用保持信心。我们将继续推进我们的战略销售计划，并与全球客户深化关系。然而，我们也在考虑一些战略选择，以便更有效地扩大我们的业务并最大化股东价值，” Astrotech 董事长兼首席执行官 Thomas B. Pickens, III 表示。</p>
<p>Astrotech 尚未设定战略选择审查过程的截止日期或明确时间表，无法保证该过程将导致任何交易或特定结果。除非董事会决定进一步披露是适当或必要的，否则公司不打算对此主题进一步评论。</p>
<p><strong>关于 Astrotech Corporation</strong></p>
<p>Astrotech（纳斯达克：ASTC）是一家质谱公司，通过其全资子公司创建、运营和扩展创新业务。每个子公司利用 Astrotech 的核心技术为专业市场服务：</p>
<ul>
<li><strong>1st Detect</strong> 开发、制造和销售用于安全和毒品筛查应用的痕迹检测系统。</li>
<li><strong>AgLAB</strong> 设计针对农业行业的过程分析仪。</li>
<li><strong>Pro-Control</strong> 生产用于工业制造中的原位化学过程控制的解决方案。</li>
<li><strong>EN-SCAN, Inc.</strong> 提供便携式、坚固的环境测试解决方案，集成气相色谱和质谱，适用于具有挑战性的现场环境。</li>
</ul>
<p><strong>前瞻性声明</strong></p>
<p>本新闻稿包含根据 1995 年《私人证券诉讼改革法》安全港条款作出的 “前瞻性声明”。此类前瞻性声明受到风险、趋势和不确定性的影响，这可能导致实际结果与前瞻性声明存在重大差异。这些声明可能通过 “旨在”、“预期”、“相信”、“考虑”、“继续”、“可能”、“估计”、“期望”、“预测”、“指导”、“打算”、“可能”、“计划”、“可能的”、“潜在的”、“预测”、“初步”、“项目”、“寻求”、“应该”、“目标”、“将” 或 “会” 或这些术语的否定形式、这些术语的变体或其他类似表达来识别。这些因素包括但不限于战略选择审查过程目标的实现、通货膨胀压力的负面影响，包括燃料成本的显著增加、全球经济状况及与这些状况相关的事件，包括乌克兰和中东的持续战争、公司对普通股发行收益的使用、我们是否能够成功完成新产品和专有技术的开发、我们是否能够获得在美国或国外市场销售我们正在开发的产品所需的 FDA 和其他监管批准、市场是否会接受我们的产品和服务，以及我们在识别、完成和整合收购方面的成功，以及公司在证券交易委员会的备案文件中描述的其他风险因素和商业考虑，包括公司最近的 10-K 表格年度报告和 10-Q 表格季度报告中的内容。本文档中的任何前瞻性声明应根据这些重要风险因素进行评估。虽然我们不打算直接收获、制造、分销或销售大麻或大麻产品，但我们可能会受到联邦或州政府执法变化的负面影响，并且我们可能会面临与不断变化的监管领域及相关不确定性相关的额外风险。这些影响可能会导致当前未知的风险和不确定性，或加剧此处提到的其他风险。尽管公司相信其前瞻性声明中反映的预期是合理的，并基于合理的假设，但无法保证这些假设是准确的，或这些预期中的任何一项将实现（全部或部分）或证明是正确的。此外，本新闻稿中包含的任何前瞻性声明仅代表公司在其发布之日的观点，不应被视为其在任何后续日期的观点。公司不承担纠正或更新这些前瞻性声明的义务，无论是由于新信息、未来事件还是其他原因，除非适用法律要求。</p>
<p>公司联系人：</p>
<p>Scott Bartley</p>
<p>首席财务官，Astrotech Corporation</p>
<p>(512) 485-9530</p>
<p>投资者联系人：</p>
<p>Matt Kreps</p>
<p>董事总经理，Darrow Associates</p>
<p>(214) 597-8200 mkreps@darrowir.com</p>
<hr/>
<p><img src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RVM09EUTFOU00zTWpjeU1EYzFJelV3TURFd09EQTVPUT09?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RVM09EUTFOU00zTWpjeU1EYzFJelV3TURFd09EQTVPUT09"/></p>
<p><img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/MzVkYTQyZDYtZDNjZi00OGEzLWExZGUtYTAxMTJjNzg0Y2UwLTUwMDEwODA5OS0yMDI1LTExLTE5LWVu/tiny/Astrotech-Corporation.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/MzVkYTQyZDYtZDNjZi00OGEzLWExZGUtYTAxMTJjNzg0Y2UwLTUwMDEwODA5OS0yMDI1LTExLTE5LWVu/tiny/Astrotech-Corporation.png"/></p>

ASTC

<p>Astrotech Corporation 宣布进行战略审查，以探索最大化股东价值的选项，包括潜在的股权融资、合并或业务出售。该公司旨在利用其质谱和气相色谱技术，在安全和环境检测等大型市场中发挥作用。审查没有设定截止日期，结果尚不确定。Astrotech 仅在必要时进行更新</p>

<p>11/19/2025 - 09:15 AM</p>
<div class="lb-trans"><p>2025 年 11 月 19 日- 上午 09:15</p>
</div><p>AUSTIN, Texas, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) today announced that its Board of Directors has initiated a review of strategic alternatives in order to explore ways to maximize shareholder value. The review will include a range of potential actions, including raising equity capital, reverse mergers, combination transactions, and the sale of all or part of the Company’s business, and other possible strategic or financial transactions.</p>
<div class="lb-trans"><p>德克萨斯州奥斯汀，2025 年 11 月 19 日（GLOBE NEWSWIRE）-- Astrotech Corporation（纳斯达克：ASTC）（“公司” 或 “Astrotech”）今天宣布，其董事会已启动战略选择的审查，以探索最大化股东价值的方法。该审查将包括一系列潜在行动，包括筹集股本、反向合并、组合交易以及出售公司全部或部分业务，以及其他可能的战略或财务交易。</p>
</div><p>“We remain confident in our differentiated mass spectrometry and gas chromatography technologies, and in the specific end market applications we have developed to create value in large end markets, such as explosives trace detection, narcotics trace detection, security screening, environmental testing and industrial controls. We continue to move forward with our strategic sales plans and advance relationships with customers around the world. However, we are also looking at strategic options that could allow us to more effectively scale our business and maximize value for our shareholders” said Thomas B. Pickens, III, Astrotech’s Chairman and Chief Executive Officer.</p>
<div class="lb-trans"><p>“我们对我们独特的质谱和气相色谱技术，以及我们为在大型终端市场（如爆炸物痕迹检测、毒品痕迹检测、安全筛查、环境测试和工业控制）创造价值而开发的特定终端市场应用保持信心。我们将继续推进我们的战略销售计划，并与全球客户深化关系。然而，我们也在考虑一些战略选择，以便更有效地扩大我们的业务并最大化股东价值，” Astrotech 董事长兼首席执行官 Thomas B. Pickens, III 表示。</p>
</div><p>Astrotech has not set a deadline or definitive timetable for the completion of the strategic alternatives review process, and there can be no assurance that this process will result in any transaction or specific outcome. The Company does not intend to comment further on this topic unless and until the Board has determined that further disclosure is appropriate or necessary.</p>
<div class="lb-trans"><p>Astrotech 尚未设定战略选择审查过程的截止日期或明确时间表，无法保证该过程将导致任何交易或特定结果。除非董事会决定进一步披露是适当或必要的，否则公司不打算对此主题进一步评论。</p>
</div><p><strong>About Astrotech Corporation</strong></p>
<div class="lb-trans"><p><strong>关于 Astrotech Corporation</strong></p>
</div><p>Astrotech (Nasdaq: ASTC) is a mass spectrometry company that creates, operates, and scales innovative businesses through its wholly owned subsidiaries. Each subsidiary leverages Astrotech’s core technology to serve specialized markets:</p>
<div class="lb-trans"><p>Astrotech（纳斯达克：ASTC）是一家质谱公司，通过其全资子公司创建、运营和扩展创新业务。每个子公司利用 Astrotech 的核心技术为专业市场服务：</p>
</div><ul>
<li><strong>1st Detect</strong> develops, manufactures, and markets trace detection systems for security and narcotics screening applications.</li>
<li><strong>AgLAB</strong> designs process analyzers tailored to the agriculture industry.</li>
<li><strong>Pro-Control</strong> produces solutions for in-situ chemical process control in industrial manufacturing.</li>
<li><strong>EN-SCAN, Inc.</strong> delivers portable, ruggedized environmental testing solutions that integrate gas chromatography and mass spectrometry for use in challenging field environments.</li>
</ul>
<div class="lb-trans"><ul>
<li><strong>1st Detect</strong> 开发、制造和销售用于安全和毒品筛查应用的痕迹检测系统。</li>
<li><strong>AgLAB</strong> 设计针对农业行业的过程分析仪。</li>
<li><strong>Pro-Control</strong> 生产用于工业制造中的原位化学过程控制的解决方案。</li>
<li><strong>EN-SCAN, Inc.</strong> 提供便携式、坚固的环境测试解决方案，集成气相色谱和质谱，适用于具有挑战性的现场环境。</li>
</ul>
</div><p><strong>Forward-Looking Statements</strong></p>
<div class="lb-trans"><p><strong>前瞻性声明</strong></p>
</div><p>This press release contains “forward-looking statements” that are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to risks, trends, and uncertainties that could cause actual results to be materially different from the forward-looking statement. These statements may be identified by terms such as “aims,” “anticipates,” “believes,” contemplates,” “continue,” “could,” “estimates,” “expect,” “forecast,” “guidance,” “intends,” “may,” “plans,” “possible,” “potential,” “predicts,” “preliminary,” “projects,” “seeks,” “should,” “targets,” “will” or “would,” or the negatives of these terms, variations of these terms or other similar expressions. These factors include, but are not limited to, achievement of the objectives of the strategic alternatives review process, the adverse impact of inflationary pressures, including significant increases in fuel costs, global economic conditions and events related to these conditions, including the ongoing wars inUkraineand the middle east, the Company’s use of proceeds from the common stock offerings, whether we can successfully complete the development of our new products and proprietary technologies, whether we can obtain the FDA and other regulatory approvals required to market our products under development inthe United Statesor abroad, whether the market will accept our products and services and whether we are successful in identifying, completing and integrating acquisitions, as well as other risk factors and business considerations described in the Company’s Securities and Exchange Commission filings including the Company’s most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. Any forward-looking statements in this document should be evaluated in light of these important risk factors. While we do not intend to directly harvest, manufacture, distribute or sell cannabis or cannabis products, we may be detrimentally affected by a change in enforcement by federal or state governments and we may be subject to additional risks in connection with the evolving regulatory area and associated uncertainties. Any such effects may give rise to risks and uncertainties that are currently unknown or amplify others mentioned herein. Although the Company believes the expectations reflected in its forward-looking statements are reasonable and are based on reasonable assumptions, no assurance can be given that these assumptions are accurate or that any of these expectations will be achieved (in full or at all) or will prove to have been correct. Moreover, such statements are subject to a number of assumptions, risks and uncertainties, many of which are beyond the control of the Company, which may cause actual results to differ materially from those implied or expressed by the forward-looking statements. In addition, any forward- looking statements included in this press release represent the Company’s views only as of the date of its publication and should not be relied upon as representing its views as of any subsequent date. The Company assumes no obligation to correct or update these forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.</p>
<div class="lb-trans"><p>本新闻稿包含根据 1995 年《私人证券诉讼改革法》安全港条款作出的 “前瞻性声明”。此类前瞻性声明受到风险、趋势和不确定性的影响，这可能导致实际结果与前瞻性声明存在重大差异。这些声明可能通过 “旨在”、“预期”、“相信”、“考虑”、“继续”、“可能”、“估计”、“期望”、“预测”、“指导”、“打算”、“可能”、“计划”、“可能的”、“潜在的”、“预测”、“初步”、“项目”、“寻求”、“应该”、“目标”、“将” 或 “会” 或这些术语的否定形式、这些术语的变体或其他类似表达来识别。这些因素包括但不限于战略选择审查过程目标的实现、通货膨胀压力的负面影响，包括燃料成本的显著增加、全球经济状况及与这些状况相关的事件，包括乌克兰和中东的持续战争、公司对普通股发行收益的使用、我们是否能够成功完成新产品和专有技术的开发、我们是否能够获得在美国或国外市场销售我们正在开发的产品所需的 FDA 和其他监管批准、市场是否会接受我们的产品和服务，以及我们在识别、完成和整合收购方面的成功，以及公司在证券交易委员会的备案文件中描述的其他风险因素和商业考虑，包括公司最近的 10-K 表格年度报告和 10-Q 表格季度报告中的内容。本文档中的任何前瞻性声明应根据这些重要风险因素进行评估。虽然我们不打算直接收获、制造、分销或销售大麻或大麻产品，但我们可能会受到联邦或州政府执法变化的负面影响，并且我们可能会面临与不断变化的监管领域及相关不确定性相关的额外风险。这些影响可能会导致当前未知的风险和不确定性，或加剧此处提到的其他风险。尽管公司相信其前瞻性声明中反映的预期是合理的，并基于合理的假设，但无法保证这些假设是准确的，或这些预期中的任何一项将实现（全部或部分）或证明是正确的。此外，本新闻稿中包含的任何前瞻性声明仅代表公司在其发布之日的观点，不应被视为其在任何后续日期的观点。公司不承担纠正或更新这些前瞻性声明的义务，无论是由于新信息、未来事件还是其他原因，除非适用法律要求。</p>
</div><p>Company Contact:</p>
<div class="lb-trans"><p>公司联系人：</p>
</div><p>Scott Bartley</p>
<div class="lb-trans"><p>Scott Bartley</p>
</div><p>Chief Financial Officer, Astrotech Corporation</p>
<div class="lb-trans"><p>首席财务官，Astrotech Corporation</p>
</div><p>(512) 485-9530</p>
<div class="lb-trans"><p>(512) 485-9530</p>
</div><p>Investor Contact:</p>
<div class="lb-trans"><p>投资者联系人：</p>
</div><p>Matt Kreps</p>
<div class="lb-trans"><p>Matt Kreps</p>
</div><p>Managing Director, Darrow Associates</p>
<div class="lb-trans"><p>董事总经理，Darrow Associates</p>
</div><p>(214) 597-8200 mkreps@darrowir.com</p>
<div class="lb-trans"><p>(214) 597-8200 mkreps@darrowir.com</p>
</div><hr/>
<div class="lb-trans"><hr/>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RVM09EUTFOU00zTWpjeU1EYzFJelV3TURFd09EQTVPUT09" alt="" original-src="https://www.globenewswire.com/newsroom/ti?nf=OTU3ODQ1NSM3MjcyMDc1IzUwMDEwODA5OQ=="/></p>
<p><img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/MzVkYTQyZDYtZDNjZi00OGEzLWExZGUtYTAxMTJjNzg0Y2UwLTUwMDEwODA5OS0yMDI1LTExLTE5LWVu/tiny/Astrotech-Corporation.png" alt="" original-src="https://ml.globenewswire.com/media/MzVkYTQyZDYtZDNjZi00OGEzLWExZGUtYTAxMTJjNzg0Y2UwLTUwMDEwODA5OS0yMDI1LTExLTE5LWVu/tiny/Astrotech-Corporation.png"/></p>

Astrotech 宣布审查战略替代方案以最大化股东价值 | ASTC 股票新闻